KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Boston Scientific (BSX) Intangibles (2016 - 2025)

Boston Scientific's Intangibles history spans 17 years, with the latest figure at $7.0 billion for Q4 2025.

  • For Q4 2025, Intangibles rose 5.01% year-over-year to $7.0 billion; the TTM value through Dec 2025 reached $7.0 billion, up 5.01%, while the annual FY2025 figure was $7.0 billion, 5.01% up from the prior year.
  • Intangibles for Q4 2025 was $7.0 billion at Boston Scientific, up from $6.7 billion in the prior quarter.
  • Across five years, Intangibles topped out at $7.0 billion in Q4 2025 and bottomed at $5.9 billion in Q4 2022.
  • The 5-year median for Intangibles is $6.2 billion (2021), against an average of $6.3 billion.
  • The largest annual shift saw Intangibles dropped 3.58% in 2022 before it rose 11.34% in 2024.
  • A 5-year view of Intangibles shows it stood at $6.1 billion in 2021, then decreased by 3.58% to $5.9 billion in 2022, then increased by 1.71% to $6.0 billion in 2023, then grew by 11.34% to $6.7 billion in 2024, then rose by 5.01% to $7.0 billion in 2025.
  • Per Business Quant, the three most recent readings for BSX's Intangibles are $7.0 billion (Q4 2025), $6.7 billion (Q4 2024), and $6.0 billion (Q4 2023).